RHINOCORT ALLERGY SPRAY OTC
Generic Name and Formulations:
Budesonide 32mcg; per nasal spray; scent- and alcohol-free.
McNeil Consumer Healthcare
Indications for RHINOCORT ALLERGY SPRAY:
To relieve symptoms of seasonal or perennial allergic rhinitis.
Adults and Children:
<6yrs: not recommended. 6–<12yrs: initially 1 spray in each nostril once daily; increase to 2 sprays per nostril once daily if no improvement; reduce to 1 spray in each nostril once daily when symptoms improve. ≥12yrs: use 2 sprays per nostril once daily; reduce to 1 spray in each nostril once daily when symptoms improve.
Do not use for treating the common cold or use more than recommended. Avoid eyes or mouth. Recent nose ulcers or surgery. Nose injury that has not healed. Eye infection. Glaucoma. Cataracts. Re-evaluate if no improvement after 2 weeks. Discontinue if exposed to chickenpox, measles, or tuberculosis, have symptoms of an infection (eg, persistent fever), change in vision, severe or frequent nosebleeds. Children 6–<12yrs: monitor and re-evaluate if treatment requires >2 months per year. Pregnancy. Nursing mothers.
Concomitant other steroid drugs for asthma, allergies, or skin rash.
Reduced growth velocity in children.
Spray—5mL (60 sprays), 8.4mL (120 sprays)
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|